Editorial: We have a cancer vaccine – why don't we use it?

Hall, '

doi:10.1046/j.1365-3156.1998.00251.x

Cited by 5 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The World Health Organisation, UNICEF and the World Bank have all advocated routine hepatitis B vaccination of children 4 . Unfortunately, it has proven much too expensive for many countries and there is little hope of future implementation 5 . It is a tragedy that African infants continue to be denied this safe and effective vaccine.…”

Section: Discussionmentioning

confidence: 99%

A Preventable Cause of Acute Abdomen

Hadjianastassiou

Eddleston

Toogood

et al. 2001

Int J Clinical Practice

View full text Add to dashboard Cite

SUMMARYHaemoperitoneum is an extremely rare presentation of hepatocellular carcinoma in the industrialised world. We present the first reported case in the UK. In contrast, up to 10% of hepatocellular carcinomas in Africa present in this way, the median time between presentation and death being just six weeks. Hepatitis B infection at birth and during childhood is the major cause of hepatocellular carcinoma in the developing world. The World Health Organisation, UNICEF and the World Bank have all advocated routine hepatitis B vaccination of children. This can reduce the burden of disease in these communities, among people in their productive years of life.

show abstract

Section: Discussionmentioning

confidence: 99%

A Preventable Cause of Acute Abdomen

Hadjianastassiou

Eddleston

Toogood

et al. 2001

Int J Clinical Practice

View full text Add to dashboard Cite

show abstract

“…These are examples of how effective implementation of HB immunisation can provide a vehicle for earlier contact with and better care for mothers and their newborn, strengthening the whole primary health care system, 23,27,30 as can polio immunisation campaigns. 31 It is an important example of how the dichotomising distinction which is sometimes drawn between specific vertical health programmes such as immunisation on one hand; and comprehensive, community development oriented primary health care on the other, may be quite inappropriate.…”

Section: Control Of Hepatitis Bmentioning

confidence: 99%

Immunisation strategies for viral diseases in developing countries

Ruff

1999

Rev. Med. Virol.

View full text Add to dashboard Cite

In just under a quarter of a century, the Expanded Programme on Immunisation has been associated with an increase in infant immunisation coverage from around 5% to 80%, and the prevention of at least 3 million deaths annually, at very low cost. The global target of poliomyelitis eradication by the year 2000 appears feasible. Measles is the next likely target for eradication via immunisation, through ‘catch‐up’, ‘keep up’ and ‘follow‐up’ strategies which have proven highly effective in the Americas. Yet much needs to be done in order to extend readily achievable immunisation benefits equitably to all the world's people and to realise the potential of existing and soon to be available vaccines for disease control and eradication, as experience with yellow fever and hepatitis B vaccines demonstrates. Unsafe injection practices are widespread, have received inadequate attention, and cause a substantial global burden of blood‐borne infections. The risk of increasing global inequity in immunisation highlights the centrality of resource allocation priorities in determining the extent to which the benefits of immunisation will be realised, particularly for new vaccines which are significantly more costly than established EPI vaccines. WHO/UNICEF strategies to target more effectively immunisation support to the neediest countries, to prioritise new vaccines, and to target carefully vaccine procurement and encourage sharply tiered vaccine pricing support both equity and sustainability. However, increasing the resources available to immunisation is vital and requires powerful advocacy on public health, moral, cost‐effectiveness and legal grounds. More appropriate resource allocation priorities could readily provide the means necessary to address both technical and operational immunisation challenges. Copyright © 1999 John Wiley & Sons, Ltd.

show abstract

Viral Hepatitis

Rizzetto¹,

Zoulim²

2007

Textbook of Hepatology

View full text Add to dashboard Cite

Editorial: We have a cancer vaccine – why don't we use it?

Cited by 5 publications

References 9 publications

A Preventable Cause of Acute Abdomen

A Preventable Cause of Acute Abdomen

Immunisation strategies for viral diseases in developing countries

Viral Hepatitis

Contact Info

Product

Resources

About